Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia (CML) and Ph+ ALL ...

Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Dasatinib tablets in multiple strengths, a generic version of Bristol ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

A recent phase II study showed that dasatinib, a novel oral agent active against BCR-ABL, induce remarkable responses in patients with CML-CP resistant or intolerant to imatinib. The study ...

R Systems International announced the launch of its IoT Smart C2C Connector. Built on Amazon Web Services (AWS), the IoT Smart C2C Connector solves challenges faced by service providers in managing ...

The company launched ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients. ANVIMO will ...